HDHale Demir

Hale Demir

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hale Demir has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mixed Epithelial and Stromal Tumor Family of Kidney (Adult Cystic Nephroma, Mixed Epithelial and Stromal Tumor): Retrospective Clinicopathological Evaluation

    by Hale Demir, Zehra Sahin, Oktay Ozman, Muhammed Demirbilek, Sami Berk Ozden, Iclal Gurses, Haydar Durak, Nesrin Uygun, Bulent Onal

    Objective: Tumors belonging to the mixed epithelial stromal tumor family (MESTF) are rare; thus clinicopathological experience about them are limited. Each epithelial and stromal component shows different patterns in these tumors. Material and Method: Clinicopathological features of 11 MESTF cases that were diagnosed between 2000 and 2021 at a single center were evaluated. Results: Ten of the 11 patients were female (F:M = 10:1). The mean age of the females was 47 (31-63) years; the male patient was 45 years old. The mean tumor diameter was 6.7 (3.5-19) cm. All tumors had varying proportions of cystic and solid components. Eight cases were well circumscribed, and the others had distinct but irregular borders. Two of the tumors with irregular borders were bulging into the renal sinus. The epithelial component was dominant in most cases. In the epithelial component, macrocyst, microcyst, and tubules were the most common patterns and the most common types of lining epithelium were flat, cuboidal and hobnail. The stromal component was variable in most cases and included hypocellular (mostly collagenous) and cellular areas. In most cases, the cellular stroma had an ovarian-like appearance. Among the other features observed, hyalinization and dystrophic calcification were common. The positivity for estrogen and progesterone receptor in the stromal component was observed in almost all female cases. Conclusion: MESTF, which has distinctive features, should be considered in the differential diagnosis of cystic kidney tumors.


  • ThinPrep sıvı bazlı sitoloji yöntemiyle hazırlanan servikal smear materyallerinin değerlendirilmesi, sito-histopatolojik korelasyon

    by Hale Demi̇r

    Amaç: Bu çalışma; servikal sitoloji (SS) materyallerinde kalite açısından yeterlilik oranını, değerlendirme için yetersiz olanların nedenlerini, epitelyal hücre anormalliği (EHA) saptama yüzdesini, atipik skuamöz hücreler/ skuamöz intraepitelyal lezyon (ASH/SIL) oranını belirlemeyi ve sito-histopatolojik korelasyon ile tanı doğruluğunu değerlendirmeyi amaçlamaktadır. Yöntem: Sıvı bazlı sitoloji (ThinPrep) yöntemi kullanılarak hazırlanan 1368 SS materyali çalışmaya alındı. SS alınan kadınların klinik özellikleri, sitolojik değerlendirme sonuçları, mevcut olanlarda eş zamanlı veya sonrasındaki servikal doku biyopsi tanıları kaydedildi. Sitolojik değerlendirme sonuçları Bethesda 2014 sınıflamasına göre kategorize edildi. Doku biyopsisi tanısına ulaşılan 36 olguda sito-histopatolojik korelasyon yapıldı. Bulgular: Elli bir (%3.7) SS materyali değerlendirme için yetersizdi. Skuamöz hücre azlığı en sık yetersizlik nedeni olup daha çok örneklemenin optimal şekilde yapılmamasıyla ilişkiliydi. Otuz sekiz SS örneğinde EHA mevcuttu (EHA oranı %2.9): 24 ASCUS, 1 ASC-H, 8 LSIL, 5 HSIL. ASH/SIL oranı 1.9’du. EHA’yı belirleme açısından, SS’nin doğruluk oranı, spesifitesi ve sensitivitesi sırasıyla %86, %91 ve %77 olarak bulundu. Sonuç: Tekrarlayan suboptimal veya yetersiz SS preparatlarıyla karşılaşıldığında laboratuvar aşamaları kontrol edilmeli ve gerekiyorsa, doğru örnekleme için ilgili kişilerle iletişime geçilmelidir. EHA oranı merkezlere göre farklılık gösterebilir. EHA’nın çoğunluğunu ASCUS oluşturur ve gereksiz ASCUS tanısı vermekten kaçınılmalıdır. ASH/SIL oranı ve sito-histopatolojik korelasyon güvenilir kalite kontrol yöntemlerinden olup her patolog veya merkez için belirlenmiş parametreler çerçevesinde kalite kontrol yapılmalıdır. Servikal biyopsi materyalleri değerlendirilirken mutlaka SS preparatı ile karşılaştırılarak incelenmeli, tanı uyumsuzluğu olan durumlarda rapora açıklayıcı notlar eklenmelidir.

  • Second Primary Malignant Tumours in Patients with Renal Cell Carcinoma

    by Hale Demir, Özden Yülek, Ertuğrul Oruç, Buğra Taygun Gülle, Deniz Nur Demir, Çetin Demirdağ, Haydar Durak, İclal Gürses, Nesrin Uygun


  • Open Access

    Villous adenoma arising in the urethra of a female with bladder augmentation history: a case report and review of the literature

    by Hale Demir, Selcuk Cin, Sinharib Citgez, Nesrin Uygun

    Villous adenomas (VAs) in the female urethra are rare with only seven cases in the English literature to our knowledge. In patients with bladder augmentation cystoplasty, the neoplasia development risk increases and most of these develop in the neobladder or anastomosis line. Only two cases of VA developing from the native bladder mucosa have been reported. Physical examination of a 76-year-old female who had a history of augmentation cystoplasty revealed a caruncula-like structure protruding from the urethral meatus. The urinary USG showed that the lesion had no relation with the bladder. The lesion was excised. Microscopically, it consisted of villous structures covered with pseudostratified intestinal type epithelium. Low-grade dysplasia was present in the epithelium but high-grade dysplasia or in-situ/invasive carcinoma was not observed. Immunohistochemical study showed positivity for CK7, CK20, EMA, CEA and CDX2. The case was reported as VA of the urethra. We presented the first VA case arising in the urethra of a female patient with intestinal bladder augmentation. Excision is curative for pure VAs. Transformation to carcinoma or recurrence has not been reported. However, in one third of the cases, a malignant tumor may accompany the lesion. Therefore, all excision material should be examined carefully. Routine endoscopic follow-up should be performed in cases with bladder augmentation.


  • Open Access

    Prognostic value of aldehyde dehydrogenase 1 (ALDH1) in invasive breast carcinomas

    by Hale Demir, Ozgecan Dulgar, Bugra Taygun Gulle, Hande Turna, Sennur Ilvan

    Aldehyde dehydrogenase 1 (ALDH1) has been identified as a marker of cancer stem cells in breast cancer (BC). Recent studies showed that ALDH1 expression is correlated with poor prognostic parameters and worse clinical outcome in BC. We evaluated ALDH1 expression by immunohistochemistry in a series of 217 invasive BCs and investigated the correlation between ALDH1 expression and clinicopathological parameters, molecular subtypes (luminal A, luminal B, human epidermal growth factor receptor 2 [HER2] type, and triple-negative BC [TNBC]), and patient survival. There was a significant association between ALDH1 expression and tumor grade (p < 0.001), i.e., the expression of ALDH1 was higher in high-grade tumors. ALDH1 expression was significantly associated with estrogen and progesterone receptor (ER and PR) negativity (p < 0.001) and HER2 positivity (p = 0.001). ALDH1 expression ratios were higher in HER2 type and TNBC. There was a statistically significant correlation between ALDH1 negativity and luminal A subtype (p < 0.001). The overall and disease free survival were shorter in ALDH1+ tumors, although without statistical significance. We confirm that ALDH1 is a potentially important, poor prognostic factor in BC, associated with high histological grade, ER/PR negativity and HER2 positivity. For more accurate results, ALDH1 expression should be evaluated in larger case series including various types/subtypes of BC.


  • Open Access

    Serous Ovarian Carcinoma Recurring as Malignant Mixed Mullerian Tumor

    by Demir Hale, Demiroz Ahu Senem, Aydin Ovgu, Erenel Hakan, Ilvan Sennur, Calay Zerrin, Demirkiran Fuat

    Only five cases of recurrence of malignant mixed Mullerian tumor (carcinosarcoma) from the ovarian carcinoma have been published in the literature to our knowledge. A 64-year-old woman first underwent a total abdominal hysterectomy and bilateral salpingo-oophorectomy because of pelvic mass. Histological diagnosis was serous papillary carcinoma of the left ovary. After six courses of chemotherapy, CA125 level returned to normal range. However, she had persistent multiple mediastinal and para-aortic lymphadenopathies in spite of additional six courses of chemotherapy. Then she underwent the second operation about 2 years after primary surgery. Multiple excisional biopsies were taken from subcutaneous tissue, over the bowels and the left external iliac artery. The histopathological diagnosis which was confirmed by immunohistochemical study was malignant mixed Mullerian tumor for all metastatic foci. A rare case of ovarian serous papillary carcinoma recurring as malignant mixed Mullerian tumor is reported. Only five cases of recurrence of malignant mixed Mullerian tumor (carcinosarcoma) from the ovarian carcinoma have been published in the literature to our knowledge. A 64-year-old woman first underwent a total abdominal hysterectomy and bilateral salpingo-oophorectomy because of pelvic mass. Histological diagnosis was serous papillary carcinoma of the left ovary. After six courses of chemotherapy, CA125 level returned to normal range. However, she had persistent multiple mediastinal and para-aortic lymphadenopathies in spite of additional six courses of chemotherapy. Then she underwent the second operation about 2 years after primary surgery. Multiple excisional biopsies were taken from subcutaneous tissue, over the bowels and the left external iliac artery. The histopathological diagnosis which was confirmed by immunohistochemical study was malignant mixed Mullerian tumor for all metastatic foci. A rare case of ovarian serous papillary carcinoma recurring as malignant mixed Mullerian tumor is reported.